Security key
00791X100
AEON Biopharma, Inc. - Class A Common Stock (AEON)
CUSIP: 00791X100
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Class A Common Stock
- Shares outstanding
- 39,736,842
- Total 13F shares
- 9,423,837
- Share change
- -47,753
- Total reported value
- $8,730,840
- Price per share
- $1.05
- Number of holders
- 25
- Value change
- -$432,476
- Number of buys
- 13
- Number of sells
- 11
Report period
Q2 2024
Institutions
25
Top holders
10
AEON full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
AEON Biopharma, Inc. SEC filings
AEON Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00791X100
Recent filing periods:
Top shareholders of AEON - AEON Biopharma, Inc. - Class A Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. |
13F
|
Company |
9.2%
|
3,675,000
|
$42,630,000 | — | 31 Mar 2024 | |
| Atalaya Capital Management LP |
13F
|
Company |
9.2%
|
3,675,000
|
$36,235,500 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.9%
|
758,992
|
$8,804,307 | — | 31 Mar 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.65%
|
257,977
|
$2,992,534 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.64%
|
255,423
|
$2,962,906 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.45%
|
179,595
|
$2,083,836 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.43%
|
169,158
|
$1,962,233 | — | 31 Mar 2024 | |
| Formidable Asset Management, LLC |
13F
|
Company |
0.17%
|
68,193
|
$791,039 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.15%
|
59,815
|
$693,854 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
59,550
|
$690,780 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
55,987
|
$649,449 | — | 31 Mar 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
55,062
|
$638,719 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
48,813
|
$566,230 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
36,250
|
$420,500 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.07%
|
28,498
|
$330,577 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
22,995
|
$266,742 | — | 31 Mar 2024 | |
| Shaolin Capital Management LLC |
13F
|
Company |
0.05%
|
21,380
|
$248,008 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.04%
|
14,400
|
$167,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
10,404
|
$120,687 | — | 31 Mar 2024 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.03%
|
10,001
|
$116,012 | — | 31 Mar 2024 | |
| LMR Partners LLP |
13F
|
Company |
0.02%
|
6,608
|
$76,653 | — | 31 Mar 2024 | |
| GHP Investment Advisors, Inc. |
13F
|
Company |
0%
|
1,095
|
$12,702 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
967
|
$11,217 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0%
|
901
|
$10 | — | 31 Mar 2024 | |
| Catalyst Funds Management Pty Ltd |
13F
|
Company |
0%
|
285
|
$3,306 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
139
|
$1,612 | — | 31 Mar 2024 | |
| DUPONT CAPITAL MANAGEMENT CORP |
13F
|
Company |
0%
|
3
|
$35 | — | 31 Mar 2024 | |
| Priveterra Sponsor, LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
14,013,205
mixed-class rows
|
$138,891,630 | — | 21 Jul 2023 | |
| Strathspey Crown Holdings Group, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,031,773
|
$20,317,730 | — | 11 Aug 2023 | |
| BARCLAYS PLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
702,645
|
— | — | 20 Feb 2023 |
Institutional Holders of AEON Biopharma, Inc. - Class A Common Stock (AEON) as of Q2 2024
As of 30 Jun 2024,
AEON Biopharma, Inc. - Class A Common Stock (AEON) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,423,837 shares.
The largest 10 holders included
Polar Asset Management Partners Inc., Atalaya Capital Management LP, VANGUARD GROUP INC, BlackRock Inc., Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, Formidable Asset Management, LLC, Davidson Kempner Capital Management LP, STATE STREET CORP, and BOOTHBAY FUND MANAGEMENT, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
26
Q2 2024 holders
25
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.